Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HHAT | Q5VTY9 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetylcysteine SCHEMBL5080784 | 0.81 | SMN1; SMN2 (0.53) | SMN1; SMN2ACE | |
| SCHEMBL691494 | 0.76 | HSD17B10 (0.41) | SMN1; SMN2 | |
| SCHEMBL8893574 | 0.74 | L3MBTL1 (0.43) | TSHRKMT2ASMN1; SMN2CYP2C19ACE | |
| SCHEMBL28681399 | 0.67 | HHAT (0.46) | POLBHHATMTNR1BACE | |
| SCHEMBL21515965 | 0.64 | SIRT1 (0.42) | POLBHHATMTNR1BSMN1; SMN2SIRT1 | |
| SCHEMBL17541277 | 0.63 | — | — | |
| SCHEMBL992740 | 0.63 | — | — | |
| SCHEMBL6518287 | 0.61 | ATM (0.47) | POLBATMACEMMP2ANPEP | |
| SCHEMBL22636529 | 0.61 | ACE (0.32) | POLBACE | |
| SCHEMBL22636530 | 0.61 | ACE (0.32) | POLBACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008012756-A2 | PEST ATTRACTANT COMPOSITION | ACTIVETRAD (PROPRIETARY) LIMITED (ZA) | 2008-01-31 | — | — | WO | claimed |
| CN-121449569-B | Acetylthioproline anthracene methyl ester for photosensitive resin composition and application thereof | 湖南初源新材料股份有限公司 | 2026-04-17 | — | — | CN | disclosed |
| CN-121449569-A | Acetylthioproline anthracene methyl ester for photosensitive resin composition and application thereof | 湖南初源新材料股份有限公司 | 2026-02-03 | — | — | CN | disclosed |
| US-20240237648-A1 | SYNERGISTIC OIL DISPERSION AGROCHEMICAL COMPOSITION CONTAINING SPINETORAM | RAJDHANI PETROCHEMICALS PRIVATE LIMITED (IN) | 2024-07-18 | — | — | US | disclosed |
| US-20240206459-A1 | SYNERGISTIC AGROCHEMICAL OIL DISPERSION FORMULATION | RAJDHANI PETROCHEMICALS PRIVATE LIMITED (IN) | 2024-06-27 | — | — | US | disclosed |
| WO-2022249204-A1 | SYNERGISTIC OIL DISPERSION AGROCHEMICAL COMPOSITION CONTAINING SPINETORAM | RAJDHANI PETROCHEMICALS PRIVATE LIMITED (IN) | 2022-12-01 | — | — | WO | disclosed |
| WO-2022224275-A1 | SYNERGISTIC AGROCHEMICAL OIL DISPERSION FORMULATION | RAJDHANI PETROCHEMICALS PRIVATE LIMITED (IN) | 2022-10-27 | — | — | WO | disclosed |
| CN-114711247-A | Agricultural composition containing lecithin and hemiphyllin | 渭南东旺农华生物科技有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-110881468-B | Crop growth regulator composition and application thereof | 郑州郑氏化工产品有限公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-110881468-A | Crop growth regulator composition and application thereof | 郑州郑氏化工产品有限公司 | 2020-03-17 | — | — | CN | disclosed |
| EP-1135371-A1 | BETA-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 2001-09-26 | — | — | EP | disclosed |
| EP-1095036-A1 | CINNAMIC ACID DERIVATIVES AS CELL ADHESION MOLECULES | CELLTECH THERAPEUTICS LIMITED (GB) | 2001-05-02 | — | — | EP | disclosed |
| EP-1066316-A1 | CINNAMIC ACID DERIVATIVES HAVING CELL ADHESION MODULATING ACTIVITY | CELLTECH THERAPEUTICS LIMITED (GB) | 2001-01-10 | — | — | EP | disclosed |
| WO-2000032575-A1 | β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000001690-A1 | CINNAMIC ACID DERIVATIVES AS CELL ADHESION MOLECULES | CELLTECH THERAPEUTICS LIMITED (GB) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999047547-A1 | CINNAMIC ACID DERIVATIVES HAVING CELL ADHESION MODULATING ACTIVITY | CELLTECH THERAPEUTICS LIMITED (GB) | 1999-09-23 | — | — | WO | disclosed |
| US-5591758-A | ANGINA PECTORIS TREATMENT | LABORATOIRES HOECHST, SA (FR) | 1997-01-07 | — | — | US | disclosed |
| EP-0604459-A1 | Organic nitrates, methods for preparing same and use thereof for treating cardiovascular diseases | LABORATOIRES HOECHST S.A. (FR) | 1994-07-06 | — | — | EP | disclosed |
| EP-0530887-A1 | Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases | LABORATOIRES HOECHST S.A. (FR) | 1993-03-10 | — | — | EP | disclosed |
| WO-1993003037-A1 | ORGANIC NITRATES, METHODS FOR PREPARING SAME AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES | LABORATOIRES HOECHST, SOCIÉTÉ ANONYME (FR) | 1993-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240206459-A1 | SYNERGISTIC AGROCHEMICAL OIL DISPERSION FORMULATION | DDT, SQLE, SCD | POLB 1915/4885ATM 875/4885MEN1 3937/4885 |
| US-20240237648-A1 | SYNERGISTIC OIL DISPERSION AGROCHEMICAL COMPOSITION CONTAINING SPINETORAM | IPO9, PDE12, SOST | POLB 3998/4885ATM 1785/4885MEN1 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.